Literature DB >> 17870458

The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK.

Ivan Le Jeune1, Jonathan Gribbin, Joe West, Chris Smith, Paul Cullinan, Richard Hubbard.   

Abstract

BACKGROUND: The aim of this study was to use a longitudinal computerised health care dataset (The Health Improvement Network) to provide information on the overall incidence of cancer, and on the incidence of organ-specific cancers, in people with idiopathic pulmonary fibrosis (IPF) and sarcoidosis in comparison to the general population.
METHODS: Incident cases of IPF and sarcoidosis were identified with up to four controls matched by age, gender and general practice. Cancer incidence rates were compared between cohorts using Cox regression and adjusting for age, gender and smoking habit.
RESULTS: One thousand and sixty-four incident cases of IPF (mean age at diagnosis 71.5 years; 62.4% male) were identified. Overall, the incidence of cancer was increased in people with IPF compared to the general population (rate ratio 1.51; 95% CI 1.20-1.90), but this was largely due to a marked increase in the incidence of lung cancer (rate ratio 4.96; 95% CI 3.00-8.18). One thousand one hundred and fifty-three incident cases of sarcoidosis (mean age at diagnosis 47.0 years; 47.2% male) were identified. There was an overall increased incidence of cancer in sarcoidosis (rate ratio 1.65; 95% CI 1.22-2.24) and this was largely explained by an increase in the incidence of skin cancers (rate ratio 1.86; 95% CI 1.11-3.11).
CONCLUSIONS: This study provides further evidence of a marked increase in the incidence of lung cancer in people with IPF, but we found no increase in the risk of other cancers. People with sarcoidosis did have an increase risk of skin cancers, but not cancers at other sites.

Entities:  

Mesh:

Year:  2007        PMID: 17870458     DOI: 10.1016/j.rmed.2007.07.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  80 in total

1.  Sarcoidosis and the occurrence of malignant diseases.

Authors:  Norbert Blank; Hanns-Martin Lorenz; Anthony D Ho; Mathias Witzens-Harig
Journal:  Rheumatol Int       Date:  2014-03-23       Impact factor: 2.631

Review 2.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 3.  [Characterization and management of incidentally detected solitary pulmonary nodules].

Authors:  C Menzel; O W Hamer
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

4.  Ceramics manufacturing contributes to ambient silica air pollution and burden of lung disease.

Authors:  Chung-Min Liao; Bo-Chun Wu; Yi-Hsien Cheng; Shu-Han You; Yi-Jun Lin; Nan-Hung Hsieh
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-24       Impact factor: 4.223

Review 5.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 6.  [Management of solid pulmonary nodules].

Authors:  F Poschenrieder; L Beyer; B Rehbock; S Diederich; D Wormanns; C Stroszczynski; O W Hamer
Journal:  Radiologe       Date:  2014-05       Impact factor: 0.635

Review 7.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

8.  Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung.

Authors:  Takuya Ueda; Keiju Aokage; Hiroyoshi Nishikawa; Shinya Neri; Hiroshi Nakamura; Masato Sugano; Kenta Tane; Tomohiro Miyoshi; Motohiro Kojima; Satoshi Fujii; Takeshi Kuwata; Atsushi Ochiai; Masahiko Kusumoto; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-12       Impact factor: 4.553

Review 9.  New perspectives on management of idiopathic pulmonary fibrosis.

Authors:  Silvia Puglisi; Sebastiano Emanuele Torrisi; Virginia Vindigni; Riccardo Giuliano; Stefano Palmucci; Massimiliano Mulè; Carlo Vancheri
Journal:  Ther Adv Chronic Dis       Date:  2016-02-01       Impact factor: 5.091

10.  Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis.

Authors:  Naohiro Watanabe; Hiroyuki Taniguchi; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Osamu Nishiyama; Masashi Kondo; Yoshinori Hasegawa
Journal:  Int J Clin Oncol       Date:  2013-04-17       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.